First Manhattan’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-38,575
| Closed | -$2.04M | – | 1454 |
|
|
2020
Q3 | $2.04M | Hold |
38,575
| – | – | 0.01% | 301 |
|
|
2020
Q2 | $2.36M | Sell |
38,575
-4,875
| -11% | -$282K | 0.01% | 289 |
|
|
2020
Q1 | $2.46M | Sell |
43,450
-2,100
| -5% | -$120K | 0.02% | 274 |
|
|
2019
Q4 | $2.59M | Hold |
45,550
| – | – | 0.01% | 305 |
|
|
2019
Q3 | $2.44M | Buy |
45,550
+9,160
| +25% | +$533K | 0.01% | 310 |
|
|
2019
Q2 | $2.17M | Hold |
36,390
| – | – | 0.01% | 320 |
|
|
2019
Q1 | $2.27M | Sell |
36,390
-5,590
| -13% | -$370K | 0.01% | 327 |
|
|
2018
Q4 | $2.54M | Sell |
41,980
-5,400
| -11% | -$323K | 0.02% | 309 |
|
|
2018
Q3 | $2.77M | Buy |
47,380
+8,000
| +20% | +$408K | 0.01% | 329 |
|
|
2018
Q2 | $1.77M | Buy |
39,380
+13,000
| +49% | +$559K | 0.01% | 376 |
|
|
2018
Q1 | $1.17M | Sell |
26,380
-3,900
| -13% | -$164K | 0.01% | 416 |
|
|
2017
Q4 | $1.31M | Sell |
30,280
-4,900
| -14% | -$220K | 0.01% | 409 |
|
|
2017
Q3 | $1.64M | Sell |
35,180
-2,000
| -5% | -$95.8K | 0.01% | 378 |
|
|
2017
Q2 | $1.84M | Sell |
37,180
-2,000
| -5% | -$105K | 0.01% | 368 |
|
|
2017
Q1 | $2.15M | Sell |
39,180
-2,000
| -5% | -$106K | 0.01% | 345 |
|
|
2016
Q4 | $2.29M | Sell |
41,180
-2,200
| -5% | -$106K | 0.01% | 317 |
|
|
2016
Q3 | $1.98M | Hold |
43,380
| – | – | 0.01% | 336 |
|
|
2016
Q2 | $1.73M | Hold |
43,380
| – | – | 0.01% | 357 |
|
|
2016
Q1 | $1.51M | Buy |
43,380
+16,500
| +61% | +$606K | 0.01% | 368 |
|
|
2015
Q4 | $1.16M | Hold |
26,880
| – | – | 0.01% | 409 |
|
|
2015
Q3 | $1.17M | Buy |
26,880
+24,000
| +833% | +$1.3M | 0.01% | 402 |
|
|
2015
Q2 | $148K | Hold |
2,880
| – | – | ﹤0.01% | 752 |
|
|
2015
Q1 | $112K | Hold |
2,880
| – | – | ﹤0.01% | 802 |
|
|
2014
Q4 | $111K | Hold |
2,880
| – | – | ﹤0.01% | 813 |
|
|
2014
Q3 | $101K | Sell |
2,880
-23,420
| -89% | -$688K | ﹤0.01% | 818 |
|
|
2014
Q2 | $709K | Sell |
26,300
-2,000
| -7% | -$52.1K | ﹤0.01% | 463 |
|
|
2014
Q1 | $733K | Buy |
28,300
+9,000
| +47% | +$216K | ﹤0.01% | 460 |
|
|
2013
Q4 | $418K | Sell |
19,300
-700
| -4% | -$14.3K | ﹤0.01% | 542 |
|
|
2013
Q3 | $389K | Hold |
20,000
| – | – | ﹤0.01% | 544 |
|
|
2013
Q2 | $328K | Buy |
+20,000
| New | +$322K | ﹤0.01% | 568 |
|
Other funds holding BSTC
First Manhattan's BSTC Position: Q4 2020 in Review
First Manhattan sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 38,575 shares — an estimated $2.04M sold.
First Manhattan first reported a position in BSTC in Q2 2013 and held it in 30 quarters. The position peaked at $2.77M in Q3 2018. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- First Manhattan reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- First Manhattan sold 38,575 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $2.04M.
- First Manhattan first reported a position in BioSpecifics Technologies Corp. in Q2 2013 and held it in 30 quarters.
- First Manhattan's BioSpecifics Technologies Corp. position peaked at $2.77M in Q3 2018.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on First Manhattan's 13F filing for Q4 2020, filed 16 Feb 2021.